Combination of genetics and the PSA test is useful for predicting the risk of prostate cancer that enables stratifying the population into different risk groups that may be a basis for the development of personalized screening for prostate cancer [50,51]. The gene discussed is KLK3; the disease is Familial prostate cancer.